PDCD1 and cutaneous squamous cell carcinoma: reported three cases of PLWH on cART treated with anti-PD-1 for metastatic prostate cancer (treatment with pembrolizumab for two cases) and for advanced cutaneous squamous cell carcinoma (treatment with cemiplimab for one case), respectively.